Related Experiment Video
Updated: Apr 26, 2026

08:31
Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia
Published on: October 17, 2025
815
Radiation-induced myeloid leukemia in murine models
Leena Rivina, Michael Davoren1, Robert H Schiestl
1Department of Environmental Health Sciences, University of California, Los Angeles, 650 Charles E, Young Dr, South, CHS 71-295, Los Angeles, CA 90095, USA. mdavoren@ucla.edu.
Human Genomics
|July 27, 2014
Summary
Radiation therapy increases cancer risk, necessitating new treatments for secondary cancers. The laboratory mouse (Mus musculus) is a key model for studying radiation-induced leukemia and developing therapies.
Area of Science:
- Oncology
- Radiation Biology
- Genetics
- Animal Models
Background:
- Radiation therapy is a critical cancer treatment, but it increases the risk of secondary cancers.
- Developing effective treatments for radiation-induced neoplasias requires reliable preclinical models.
- Radiation-induced leukemogenesis involves complex genomic alterations.
Purpose of the Study:
- To review established laboratory mouse (Mus musculus) models for radiation-induced myeloid leukemia.
- To discuss methods for inducing radiation-induced myeloid leukemia in these models.
- To highlight the relevance of mouse models in understanding radiation-induced carcinogenesis.
Main Methods:
- Review of inbred and F1 hybrid Mus musculus strains.
- Discussion of radiation exposure protocols for leukemia induction.
- Analysis of genomic and molecular changes associated with radiation-induced leukemia.
Main Results:
- Mus musculus is a highly relevant model due to its sequenced genome and physiological similarities to humans.
- Specific inbred and F1 hybrid mouse models are suitable for studying radiation-induced myeloid leukemia.
- Understanding molecular pathologies, including genomic changes, is crucial for therapeutic development.
Conclusions:
- Mus musculus models are indispensable for research into radiation-induced myeloid leukemia.
- These models facilitate the study of molecular mechanisms and the testing of novel therapeutic agents.
- Further research using these models is essential for reducing the incidence and improving the treatment of secondary radiation-induced cancers.

